Eli Lilly | LLY - Interest Income

Stock Price
1,003.46
Daily Change
-40.67 -3.90%
Monthly
-3.65%
Yearly
21.47%
Q1 Forecast
1,005.21

Eli Lilly reported $40M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
AbbVie USD 62M 11M Jun/2025
Abbott USD 77M 6M Sep/2025
ALKERMES USD 11.09M 949K Jun/2025
AstraZeneca USD 68M 16M Jun/2025
Baxter International USD 14M 3M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 40M 8.3M Jun/2025
Gilead Sciences USD 73M 21M Jun/2025
GlaxoSmithKline GBP 50M 4M Jun/2025
Glaxosmithkline GBP 26M 24M Sep/2025
J&J USD 2.12 0.17 Sep/2025
Medtronic USD 114M 23M Jan/2025
Merck USD 96M 27M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 114M 38M Sep/2025
Sanofi EUR 114M 38M Sep/2025
United Therapeutics USD 51.3M 200K Jun/2025
Zoetis USD 19M 4M Jun/2025